The Importance of Reporting Patient Recruitment Details in Phase III Trials
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- February 20, 2006
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Clinical Trials, Phase III as Topic (MeSH)
- Humans (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Patient Selection (MeSH)
- Research Design (MeSH)
published in
- Journal of Clinical Oncology Journal